Dekeyne, A., “Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis”, Neuropharmacology, 38 (2), (Mar. 1999), pp. 415-423. |
Baxter, G., “5-HT2 receptor subtypes: a family re-united?”, Trends in Pharmacological Reviews, 16, (1995),pp. 105-110. |
Bos, M., “Novel Antagonists of 5HT2C Receptors. Synthesis and Biological Evaluation of Substituted 2-(Indol-1-yl)-1-methylethylamines and 2-(Indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved Therapeutics for Obsessive Compulsive Disorder”, Journal of Medicinal Chemistry, 40 (17), (Aug. 15, 1997), pp. 2762-2769. |
Bromidge, S.M., “Novel and Selective 5-HT2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitive Structure-Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines”, Journal of Medicinal Chemistry, 41 (10), (May 7, 1998), pp. 1598-1612. |
Dekeyne, A., “Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis”, Neuropharmacology, 38 (2), (Mar. 1999), pp. 415-423. |
Artemenko, G.N., “Pharmacological activity spectra of some azepine- and benzoxepinoindole derivatives”, CAPLUS Abstract, (1972), 1 pg. |
Glennon, R.A., “Serotonin Receptors: Clinical Implications”, Neuroscience & Behavioral Reviews, 14 (1), (1990), pp. 35-47. |
Hoyer, D., “VII. International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine (Serotonin)”, Pharmacological Reviews, 46 (2), (Jun. 1994), pp. 157-203. |
Jenck, F., “The role of 5-HT2C receptors in affective disorders”, Exp. Opin, Invest. Drugs, 7 (10), (1998), pp. 1587-1599. |
Kennett, G.A., et al., “5-HT drugs and eating disorders”, IDrugs, 1 (4), (1998), pp. 456-470. |
Martin, J.R., “5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutic Potential”, The Journal of Pharmacology and Experimental Therapeutics, 286 (2), pp. 913-924. |
Zagorevskii, V.A., et al., “Synthesis and reactions of 2,2-dimethyl-4-chloromethyl-1,2,34-tetrahydro-gamma-carboline”, Chemical Abstracts Service, Accession No. 94: 121373, (1980), pp. 1387-1390. |